Multiple Sclerosis Research Innovation Fund

Students in Pharmacy class in Cooke Hall.

This fund supports clinical and translational research related to multiple sclerosis, which affects more than two million people worldwide.

At the School of Pharmacy and Pharmaceutical Sciences, our research into therapeutics for multiple sclerosis (MS) has helped lead to numerous discoveries — including a finding that that cholesterol affects the progression of the disease, an indication that MS progresses more rapidly in African American patients than in Caucasian patients, and more information about the mechanisms behind a regularly used treatment for MS. 

Our current work focuses on how the progression of this chronic, disabling neurological disease is affected by cholesterol and lipids, and by environmental and lifestyle factors such as smoking, vitamin D levels and immune responses to the Epstein-Barr virus — the common cause for mono.

By investigating the neuroimmunological and genomic mechanisms that contribute to clinical treatment responses, we strive to delineate the interactions among patient-specific, environmental and genetic factors that contribute to inter-individual differences in disease progression.

Our unique multi-disciplinary approach leverages our researchers’ strengths in pharmaceutical sciences and bioengineering, as well as productive collaborations with scientists from clinical disciplines.

Make a Difference Now

Other Pharmacy and Pharmaceutical Sciences Funds

News from School of Pharmacy and Pharmaceutical Sciences

  • UB CIGBS Announces Stop Diabetes Progression, a New Global Community Health Site Initiative
    10/18/23
    The University at Buffalo (UB) Center for Integrated Global Biomedical Sciences (CIGBS) has announced plans to launch, Stop Diabetes Progression, a new health initiative, focusing on the creation of community-based education networks in Western New York, Jamaica and Zimbabwe to engage individuals with pre-diabetes and those with an established diagnosis of diabetes mellitus. The goal of this new initiative is to stop the progression of the disease for both groups.
  • Pattin appointed clinical associate professor in the Division of Outcomes and Practice Advancement
    5/19/23
    In July, Anthony Pattin, PharmD, will join University at Buffalo School of Pharmacy and Pharmaceutical Sciences (SPPS) faculty as a clinical associate professor in the Division of Outcomes and Practice Advancement (OPA), Department of Pharmacy Practice. In this post, Pattin will coordinate and teach pharmacy law and maintain an experiential training site and research program in community pharmacy practice.
  • UB SPPS showcases research and scholarship at 2023 ACCP Annual Meeting
    12/6/23
    Faculty, residents, fellows and students from the University at Buffalo (UB) School of Pharmacy and Pharmaceutical Sciences (SPPS) attended the American College of Clinical Pharmacy (ACCP) Annual Meeting in Dallas, TX, from November 11-14 to showcase our school’s research and scholarship with the national clinical pharmacy community.
  • Meaney named ACCP Fellow
    8/14/23
    Calvin Meaney, PharmD, clinical associate professor and interim division head, Division of Outcomes and Practice Advancement, Department of Pharmacy Practice, has been named a Fellow of the American College of Clinical Pharmacy (ACCP).
  • Daly and Jacobs awarded national grant to lead review of community pharmacy practice transformation to advance patient care programs
    2/14/23
    Christopher Daly, PharmD, MBA, clinical assistant professor, Department of Pharmacy Practice, and David Jacobs, PharmD, PhD, assistant professor, Department of Pharmacy Practice, have received funding from the Community Pharmacy Foundation (CPF), an organization advancing pharmacy practice and patient care delivery through grant funding and resource sharing, to study national best practices for partnerships between payors and clinically integrated networks of community pharmacies to advance patient care program implementation and evaluation. 
  • Mark J. Sinnett BS ’83, PharmD ’87: 2023 UB Distinguished Alumni Award
    8/1/23
    BUFFALO, N.Y. — Mark J. Sinnett BS ’83, PharmD ’87 is a recipient of a 2023 University at Buffalo Distinguished Alumni Award. This award is given to alumni who have made a significant impact on the university at-large and also to the programs and students at the UB School of Pharmacy and Pharmaceutical Sciences (SPPS).
  • Katche appointed clinical assistant professor in the Division of Outcomes and Practice Advancement
    5/19/23
    Christ Ange (Angel) Katche, PharmD ’19, MBA ’19, BCACP, will join University at Buffalo School of Pharmacy and Pharmaceutical Sciences (SPPS) faculty in July as a clinical assistant professor in the Division of Outcomes and Practice Advancement, Department of Pharmacy Practice. In this role, her primary responsibility will be to coordinate and teach topics in ambulatory care and business, engage in community and global health initiatives, and maintain an experiential training site and research program in ambulatory care pharmacy practice.